Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts.
OBJECTIVE
The aim of this study was to compare the expression of nuclear factor kappaB (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) in odontogenic epithelial tumors and dentigerous cysts.


METHODS
The expression of these molecules was evaluated in solid/multicystic ameloblastomas (n = 12) and unicystic ameloblastomas (n = 8), keratocystic odontogenic tumors (n = 19), dentigerous cysts (n = 9), and dental follicles (n = 9) by immunohistochemistry.


RESULTS
In odontogenic epithelium, a similar expression of RANK, RANKL, and OPG was observed in all samples. With regard to stroma, the number of RANK-positive and RANKL-positive cells was higher in solid/multicystic ameloblastomas compared with dentigerous cysts. Dental follicles had lower numbers of RANK-positive, RANKL-positive, and OPG-positive cells than solid/multicystic ameloblastomas and keratocystic odontogenic tumors. The majority of solid/multicystic ameloblastomas (75%) and unicystic ameloblastomas (62.5%) had higher numbers of RANKL-positive than OPG-positive cells. In contrast, 62.4% of keratocystic odontogenic tumors and 100% of dentigerous cysts exhibited a higher content of OPG-positive than RANKL-positive cells.


CONCLUSIONS
Our results indicate differences in the RANK, RANKL, and OPG expression in odontogenic epithelial tumors. The imbalance of these factors could contribute to the differential bone/tooth resorption activity in these lesions.
da Silva
Tarcília Aparecida
TA
Department of Oral Surgery and Pathology, Dental School, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. tarcilia@odonto.ufmg.br
Batista
Aline Carvalho
AC
Mendonça
Elismauro Francisco
EF
Leles
Cláudio Rodrigues
CR
Fukada
Sandra
S
Cunha
Fernando Queiroz
FQ
D000564:Ameloblastoma / Q000378:metabolism / Q000473:pathology; D002452:Cell Count; D003803:Dentigerous Cyst / Q000378:metabolism* / Q000473:pathology; D004847:Epithelial Cells / Q000378:metabolism; D015870:Gene Expression; D006801:Humans; D007573:Jaw Neoplasms / Q000378:metabolism* / Q000473:pathology; D016328:NF-kappa B / Q000096:biosynthesis*; D009808:Odontogenic Tumors / Q000378:metabolism* / Q000473:pathology; D010014:Osteolysis / Q000473:pathology; D053244:Osteoprotegerin / Q000096:biosynthesis*; D053245:RANK Ligand / Q000096:biosynthesis*; D012391:Root Resorption / Q000473:pathology; D018709:Statistics, Nonparametric; D017154:Stromal Cells / Q000378:metabolism
D016328:NF-kappa B; D053244:Osteoprotegerin; D053245:RANK Ligand